Stockwatch > News > News Item


			ASPENBIO PHARMA INC
			Symbol			APPY

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

AspenBio Pharma Fills Key Animal Health and Quality Leadership Positions

2009-10-14 08:30 ET - News Release

CASTLE ROCK, CO -- (MARKET WIRE) -- 10/14/09

AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has added Dr. Andrew Peters to the new position of vice president of animal health and Dr. Mary Nunnally to the new position of vice president of quality management.

"These two highly-skilled professionals fill key management positions at AspenBio as we advance our lead products toward commercialization," said the company's chairman and chief executive officer, Daryl Faulkner. "Andy brings years of animal health experience to help focus and guide our strategy for this business unit. And Mary's skill set will create a solid quality process foundation as we develop and bring to market our AppyScore(TM) diagnostic test for human appendicitis."

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

AspenBio Pharma Fills Key Animal Health and Quality Leadership Positions

The remainder is available to Stockwatch subscribers. If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.